Johnson & Johnson, a global healthcare company, has recently been in the spotlight due to controversies surrounding their talc products....
Johnson & Johnson, a leading pharmaceutical company, continues to make waves in the industry with its latest submission of sNDA for the schizophrenia drug CAPLYTA to the FDA....
Johnson & Johnson, the renowned medical technology company, continues to be at the forefront of innovation in the industry....
Mark Dickinson, the leader of Johnson & Johnson Neurovascular, has announced his departure from the company....
Mark Dickinson, the leader of Johnson & Johnson Neurovascular, is leaving the company, according to sources....
Johnson & Johnson's MedTech division has received clearance from the FDA for its enhanced robotic-assisted bronchoscopy system....
Johnson & Johnson MedTech, a subsidiary of Johnson & Johnson, has appointed a new leader for its electrophysiology and neurovascular group....
Johnson & Johnson has been investing in research and development for decades in order to find effective treatments for inflammatory bowel disease (IBD)....
Johnson & Johnson (JNJ) has shown an impressive 8.9% increase in its stock price since the release of its last earnings report....
Johnson & Johnson (JNJ) has been at the forefront of medical technology, constantly innovating and developing breakthrough surgical devices that not only speed up the healing process but also save lives....
Johnson & Johnson MedTech, a subsidiary of Johnson & Johnson, has appointed a new leader for its electrophysiology and neurovascular group....
Mark Dickinson, the leader of Johnson & Johnson Neurovascular, has announced his departure from the company....
Activist investor Elliott Management has recently announced its plans to streamline operations at Phillips 66, a leading energy manufacturing and logistics company....
Honeywell International Inc., a global leader in technology and manufacturing, recently made a significant strategic move by selling its Personal Protective Equipment (PPE) business for an impressive $1....
Eli Lilly and Company, a leading pharmaceutical company, has recently announced a massive investment of $4.5 billion in the establishment of a state-of-the-art medicine foundry....